ecancermedicalscience

Research

ReDO_DB: the repurposing drugs in oncology database

6 Dec 2018
Pan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, Rica Capistrano, Sergio Crispino, Bishal Gyawali, Ilse Rooman, An MT Van Nuffel, Lydie Meheus, Vikas P Sukhatme, Gauthier Bouche

Repurposing is a drug development strategy that seeks to use existing medications for new indications. In oncology, there is an increased level of activity looking at the use of non-cancer drugs as possible cancer treatments. The Repurposing Drugs in Oncology (ReDO) project has used a literature-based approach to identify licensed non-cancer drugs with published evidence of anticancer activity. Data from 268 drugs have been included in a database (ReDO_DB) developed by the ReDO project. Summary results are outlined and an assessment of clinical trial activity also described. The database has been made available as an online open-access resource (http://www.redo-project.org/db/).

Article metrics: 4261 views
2708
1553

Related Articles

Evgenia Granina, Julia Fehniger, Douglas Kondziolka, Joshua Silverman, Andrea Downey, Dimitris Placantonakis, Franco Muggia
Emmanuel Adekunle Sajo, Kehinde Sharafadeen Okunade, Gbenga Olorunfemi, Kabiru Afolarin Rabiu, Rose Ihuoma Anorlu
Saleh A Alessy, Elizabeth A Davies, Abdul-Rahman Jazieh